Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Ampio Pharmaceuticals Stock Down 5.1 % NYSE:AMPE opened at $4.44 on Friday. The firm has a market capitalization of $3.37 million, a price-to-earnings ratio of […]

Related Keywords

Colorado ,United States ,Englewood ,Montreal ,Quebec ,Canada , ,Ampio Pharmaceuticals Inc ,Ampio Pharmaceuticals ,Institutional Investors Weigh In On Ampio Pharmaceuticals ,Ampio Pharmaceuticals Company Profile ,News Ratings For Ampio Pharmaceuticals Daily ,Millennium Management ,Ampio Pharmaceuticals Stock Down ,Vanguard Group Inc ,Virtu Financial ,Free Report ,Pharmaceuticals Stock Down ,Get Free Report ,Montreal Can ,Two Sigma Advisers ,Sigma Advisers ,Ampio Pharmaceuticals Daily ,Nyse Ampe ,Ampe ,Medical ,Initiated Coverage ,Stocknews Com ,